Archive | October, 2014

Rayno Life Science Stocks: Up 30%+ YTD After A Volatile October

Investors Whipsawed By V-Shaped Rally NASDAQ at New Highs 4631 DOW at New Highs 17,390 Investors got what was forecasted-a volatile October that moved from fear to greed in two weeks! The market was buffeted by the Ebola scare, macro analysts decrying easy money from the FED and a potential global economic slowdown. But fears […]

Continue Reading 0

Sierra SnowBlog Oct. 2014: White Is the New Orange

Update 11/5/14 No storms on the horizon for next week in the West, but check out this model for a “polar express” in the East and Midwest also creating a “blocking pattern” for the West: http://wxbrad.com/massive-storm-in-the-pacific-drives-arctic-outbreak-into-the-u-s-next-week/ Massive Storm in the Pacific drives Arctic Outbreak into the U.S Next Week. http://wp.me/p1srzO-1RZ Massive Storm in the Pacific […]

Continue Reading 0

Bio Investor Forum #2: T-Cell Therapies and Cancer Targets

Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology  is one of the hottest new areas of biopharmaceutical development and on October 7  BIO presented a Therapeutic Session on “T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets”. […]

Continue Reading 0

Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN

Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market  YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is […]

Continue Reading 0

Trading A Bottom in Small Cap Life Science Stocks …Update 11/5

11/15/14  Speculative Small Cap Stocks-Stay Away Unless Your Are A Trader Nice profits were booked on our recent small cap picks but today the sell-off was “pronounced”: Celldex (CLDX) was down 21% to $13.10 after hitting a high near $18 on October 31. GlycoMimetics (GLYC) was up 2.14% to $7.62 more than 15% above our […]

Continue Reading 0

Technical Damage to Market is Significant: Fear Factor Rules..Update 10/14

10/14 …Update 3:10p Here come the sellers late in the day on schedule. Investors are trying to hold the fort. Oil down, treasuries up, JPMorgan misses off 0.43%. XLE off 0.57%, Gold steady at 1233, biotechs mixed but GILD down 5%, industrials and technology in the green. Germany slashes growth forecast. FINVIZ.com – Stock Screener […]

Continue Reading 0

BIO Investor Forum Oct. 7-8, 2014: #1 How Fragile is the Biotech Rally?

Five Year Bull Market in Biotech  We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio Investor Forum is one of the best meetings for current issues and […]

Continue Reading 0

No Follow-Through Rally From Jobs Report: Small Caps Still Weak

NASDAQ Slides After Good Opening -Down 0.47% The enthusiasm generated by Friday’s jobs report waned after the opening. The shocking 92% decline in shares of GT Advanced Technologies , Inc.(GTAT) due to a bankruptcy filing rattled traders and drove small cap stocks down again near 2014 lows. Investors expected the Company would become a major […]

Continue Reading 0

BABA Hangover: Stock Sell-Off Continues… Update-1… 10/3 Robust Job Growth

10/3  Jobs Report Clears Path for Q4 Rally   3:30P EDT A more optimistic view of the economy was triggered by a steady gain in jobs with 248k added in August and unemployment dropping below 6% to 5.9%. But average hourly wages fell in September keeping wage growth rate around inflation at 2%. Little inflation […]

Continue Reading 0